LEN Stock Analysis: Lennar | NYSE
Residential Construction | NYSE, USA | Market Cap: 19.199m USD | 12M Return: -41.3% | US5260571048 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 256M
EPS Trend: -92.8%
Qual. Beats: 1
Rev. Trend: -72.2%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Lennar Corporation (NYSE: LEN) is a Miami, Florida-based homebuilder founded in 1954 and listed as a large-cap stock in the Consumer Discretionary sector under the GICS Homebuilding sub-industry. The company is one of the largest residential construction firms in the United States, operating primarily under the Lennar brand through four geographic homebuilding segments covering the East, Central, South Central, and West regions.
Beyond single-family attached and detached home construction, Lennar is involved in residential land acquisition and development, multifamily rental property development and management, and fund investment activities. It also operates a Financial Services segment that offers mortgage financing, title insurance, and closing services, as well as the origination and sale of securitized commercial mortgage loans.
The company targets first-time, move-up, active adult, and luxury homebuyers. Large publicly traded U.S. homebuilders like Lennar commonly operate captive mortgage businesses alongside their homebuilding operations, which helps streamline the purchase process for buyers and provides a recurring revenue stream tied to housing transactions. As a consumer discretionary industry, homebuilding is historically cyclical and sensitive to mortgage interest rates, housing affordability, and broader economic conditions.
- Mortgage rate cuts drive new home order growth
- Lumber and labor costs squeeze homebuilding gross margins
- Capital returns accelerate via buybacks and dividends
| Net Income: 1.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.66 > 1.0 |
| NWC/Revenue: 41.46% < 20% (prev 38.06%; Δ 3.40% < -1%) |
| CFO/TA 0.03 > 3% & CFO 988.0m > Net Income 1.31b |
| Net Debt (7.15b) to EBITDA (1.84b): 3.88 < 3 |
| Current Ratio: 8.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.8m) vs 12m ago -6.98% < -2% |
| Gross Margin: 9.52% > 18% (prev 11.83%; Δ -2.32% > 0.5%) |
| Asset Turnover: 93.68% > 50% (prev 99.68%; Δ -5.99% > 0%) |
| Interest Coverage Ratio: 6.83 > 6 (EBIT TTM 1.71b / Interest Expense TTM 250.2m) |
| A: 0.40 (Total Current Assets 15.1b - Total Current Liabilities 1.80b) / Total Assets 33.4b |
| B: 0.69 (Retained Earnings 22.9b / Total Assets 33.4b) |
| C: 0.05 (EBIT TTM 1.71b / Avg Total Assets 34.1b) |
| D: 1.85 (Book Value of Equity 21.6b / Total Liabilities 11.7b) |
| Altman-Z'' = 7.12 = AAA |
| DSRI: 0.65 (Receivables 924.9m/1.55b, Revenue 32.0b/34.8b) |
| GMI: 1.24 (GM 11.83% / 9.52%) |
| AQI: 1.03 (AQ_t 0.52 / AQ_t-1 0.50) |
| SGI: 0.92 (Revenue 32.0b / 34.8b) |
| TATA: 0.01 (NI 1.31b - CFO 988.0m) / TA 33.4b) |
| Beneish M = -3.13 (Cap -4..+1) = AA |
As of September 21, 2026, the stock is trading at USD 76.43 with a total of 11,836,999 shares traded. Over the past week, the price has changed by -3.98%, over one month by -10.02%, over three months by -14.31% and over the past year by -41.32%.
Current recommended Stop Loss: 72.70 (which is 4.9% or 1.4 ATR below the current price).
Lennar has received a consensus analysts rating of 3.48. Therefore, it is recommended to hold LEN.
- StrongBuy: 4
- Buy: 2
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 84.9 | 11.1% |
P/E Trailing = 12.2804
P/E Forward = 12.0192
P/S = 0.5865
P/B = 0.8731
P/EG = 11.3018
Revenue TTM = 32.0b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 1.84b USD
Long Term Debt = 6.10b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.21b USD (from shortTermDebt, last fiscal year)
Debt = 8.30b USD (corrected: LT Debt 6.10b + ST Debt 2.21b)
Net Debt = 7.15b USD (calculated: Debt 8.30b - CCE 1.15b)
Enterprise Value = 26.4b USD (19.2b + Debt 8.30b - CCE 1.15b)
Interest Coverage Ratio = 6.83 (Ebit TTM 1.71b / Interest Expense TTM 250.2m)
EV/FCF = 32.07x (Enterprise Value 26.4b / FCF TTM 821.8m)
FCF Yield = 3.12% (FCF TTM 821.8m / Enterprise Value 26.4b)
FCF Margin = 2.57% (FCF TTM 821.8m / Revenue TTM 32.0b)
Net Margin = 4.10% (Net Income TTM 1.31b / Revenue TTM 32.0b)
Gross Margin = 9.52% ((Revenue TTM 32.0b - Cost of Revenue TTM 28.9b) / Revenue TTM)
Gross Margin QoQ = 16.56% (prev 6.18%)
Tobins Q-Ratio = 0.79 (Enterprise Value 26.4b / Total Assets 33.4b)
Interest Expense / Debt = 3.01% (Interest Expense 250.2m / Debt 8.30b)
Taxrate = 25.81% (460.8m / 1.79b)
NOPAT = 1.27b (EBIT 1.71b * (1 - 25.81%))
Current Ratio = 8.38 (Total Current Assets 15.1b / Total Current Liabilities 1.80b)
Debt / Equity = 0.39 (Debt 8.30b / totalStockholderEquity, last quarter 21.6b)
Debt / EBITDA = 3.88 (Net Debt 7.15b / EBITDA 1.84b)
Debt / FCF = 8.70 (Net Debt 7.15b / FCF TTM 821.8m)
Total Stockholder Equity = 21.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 1.31b / Total Assets 33.4b)
RoE = 6.03% (Net Income TTM 1.31b / Total Stockholder Equity 21.8b)
RoCE = 6.13% (EBIT 1.71b / Capital Employed (Equity 21.8b + L.T.Debt 6.10b))
RoIC = 3.88% (NOPAT 1.27b / Invested Capital 32.6b)
WACC = 6.80% (E(19.2b)/V(27.5b) * Re(8.77%) + D(8.30b)/V(27.5b) * Rd(3.01%) * (1-Tc(0.26)))
Discount Rate = 8.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.31 | Cagr: -6.07%
[DCF] Terminal Value 77.97% ; FCFF base≈604.5m ; Y1≈693.0m ; Y5≈1.02b
[DCF] Fair Price = 38.93 (EV 15.3b - Net Debt 7.15b = Equity 8.20b / Shares 210.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -92.81 | EPS CAGR: -30.90% | SUE: 3.05 | # QB: 1
Revenue Correlation: -72.24 | Revenue CAGR: -3.15% | SUE: -1.41 | # QB: -1
EPS current Quarter (2027-02-28): EPS=0.84 | Chg30d=-1.51% | Revisions=-25% | Analysts=7
EPS current Year (2026-11-30): EPS=5.18 | Chg30d=-6.58% | Revisions=+0% | GrowthEPS=-35.7% | GrowthRev=-5.1%
EPS next Year (2027-11-30): EPS=6.38 | Chg30d=-1.63% | Revisions=-25% | GrowthEPS=+23.1% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -29% (up=1, down=3)